Literature DB >> 12171503

Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.

Bela Bodey1.   

Abstract

During the last decade, the aberrant expression of normal testicular proteins in neoplastically transformed cells became common knowledge. Cancer-testis antigens (CTAs) represent a novel family of immunogenic proteins. The genes MAGE, BAGE, GAGE, LAGE and NY-ESO-1 code for antigens that are recognised on various neoplastically transformed cells by autologous, cytolytic CD8 ( + ) T lymphocytes. The MAGE genes were initially analysed from melanomas and turned out to have an almost exclusively neoplasm specific expression pattern. In normal adult tissues, most 23 human MAGE genes are expressed only in the testis, with expression patterns suggesting that this gene family is involved in germ cell development. The SSX (synovial sarcoma on X chromosome) gene family, located on the X chromosome, encode a family of highly homologous nuclear proteins. A number of observations confirmed that all five SSX genes were expressed in normal testis. The newly detected CTA, NY-ESO-1, is regarded as one of the most immunogenic antigens ever isolated, inducing spontaneous host immune responses in 50% of patients with NY-ESO-1-expressing neoplasms. The identification of neoplasm-associated markers recognised by cellular or humoral effectors of the immune system has opened new perspectives for antigen directed, individualised antineoplastic immunotherapy. In preparation for this new era of targeted immunotherapy, a number of neoplasm-associated antigen families have been identified as targets for CD8+, cytolytic T lymphocytes in vitro and in vivo : (1) CTAs expressed in various neoplasms and in normal testis, restricted to male germ cells; (2) melanocyte differentiation antigens; (3) point mutations of normal genes; (4) antigens overexpressed in neoplastic tissues; and (5) viral antigens. Immunotherapeutic protocols directed against the CTAs have already been initiated to analyse the induction of antigen-specific cellular and humoral immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171503     DOI: 10.1517/14712598.2.6.577

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  13 in total

1.  Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients.

Authors:  Raphael B Parmigiani; Fabiana Bettoni; Maria D Vibranovski; Marilene H Lopes; Waleska K Martins; Isabela W Cunha; Fernando A Soares; Andrew J G Simpson; Sandro J de Souza; Anamaria A Camargo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

Review 2.  Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.

Authors:  Yan-Ho Cheng; Elissa Wp Wong; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-07-01

Review 3.  Programmed death-1 checkpoint blockade in acute myeloid leukemia.

Authors:  Alison Sehgal; Theresa L Whiteside; Michael Boyiadzis
Journal:  Expert Opin Biol Ther       Date:  2015-06-03       Impact factor: 4.388

Review 4.  Linking epithelial-to-mesenchymal-transition and epigenetic modifications.

Authors:  Sonja C Stadler; C David Allis
Journal:  Semin Cancer Biol       Date:  2012-06-15       Impact factor: 15.707

Review 5.  Molecular profiling of hepatocellular carcinomas by cDNA microarray.

Authors:  Lian-Hai Zhang; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

6.  High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.

Authors:  Siya Zhang; Xiaolu Zhai; Gui Wang; Jian Feng; Huijun Zhu; Liqin Xu; Guoxin Mao; Jianfei Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

7.  Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.

Authors:  Mark R Morris; Eamonn R Maher
Journal:  Genome Med       Date:  2010-09-03       Impact factor: 11.117

8.  High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.

Authors:  Xiaolu Zhai; Liqin Xu; Siya Zhang; Huijun Zhu; Guoxin Mao; Jianfei Huang
Journal:  Oncotarget       Date:  2016-01-26

9.  Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity.

Authors:  P Wojnarowicz; K Gambaro; M de Ladurantaye; M C J Quinn; D Provencher; A-M Mes-Masson; P N Tonin
Journal:  Oncogenesis       Date:  2012-09-10       Impact factor: 7.485

10.  Detection of MAGE and SSX gene expressions by RT-nested PCR using common primers in head and neck cancer.

Authors:  Dal Won Song; Seung Jin Shin; Dong Eun Kim; Seung Gon Jung; Jong Wook Park; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-06-20       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.